[Overexpression of synuclein-gamma confers resistance to antimicrotubule drugs against human hepatoma cells].

Shixiang Cheng(Chinese People's Armed Police Force Medical College Affiliated Hospital), Jian‐Dong Jiang(Ningbo University), Xuefu You(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuhuan Li(Anhui Medical University), Danqing Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Sai Zhang(Shandong Normal University), Hao Zhang(Northwestern Polytechnical University), Yueming Wang(Zhejiang Sci-Tech University), Yuping Wang
PubMed
June 1, 2010
Cited by 1

Related Papers

Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400
Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue
|Nature Immunology|2014|378
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368